These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29331501)

  • 1. Incorporating upper motor neuron health in ALS drug discovery.
    Dervishi I; Ozdinler PH
    Drug Discov Today; 2018 Mar; 23(3):696-703. PubMed ID: 29331501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyotrophic lateral sclerosis with upper motor neuron predominance: diagnostic accuracy of qualitative and quantitative susceptibility metrics in the precentral gyrus.
    Lo Russo F; Contarino VE; Conte G; Morelli C; Trogu F; Casale S; Sbaraini S; Caschera L; Genovese V; Liu C; Cinnante CM; Silani V; Triulzi FM
    Eur Radiol; 2023 Nov; 33(11):7677-7685. PubMed ID: 37606662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Patient-Specific Induced Pluripotent Stem Cells Shed Light on Drug Discovery for Amyotrophic Lateral Sclerosis.
    Lee JH; Liu JW; Lin SZ; Harn HJ; Chiou TW
    Cell Transplant; 2018 Sep; 27(9):1301-1312. PubMed ID: 30033758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Edaravone May Prevent Ferroptosis in ALS.
    Spasić S; Nikolić-Kokić A; Miletić S; Oreščanin-Dušić Z; Spasić MB; Blagojević D; Stević Z
    Curr Drug Targets; 2020; 21(8):776-780. PubMed ID: 32077821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of upper and lower motor neuron burden on diagnostic certainty, and clinical course of spinal-onset amyotrophic lateral sclerosis: a cluster-based approach.
    Milella G; Zoccolella S; Giugno A; Filardi M; Urso D; Nigro S; Tafuri B; Tamburrino L; Gnoni V; Logroscino G
    J Neurol; 2023 Oct; 270(10):4868-4875. PubMed ID: 37338613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.
    Noto Y; Shibuya K; Vucic S; Kiernan MC
    Expert Rev Neurother; 2016 Oct; 16(10):1147-54. PubMed ID: 27314534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy.
    Morello G; Cavallaro S
    Future Med Chem; 2015; 7(10):1335-59. PubMed ID: 26144267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NU-9 improves health of hSOD1
    Genç B; Gautam M; Helmold BR; Koçak N; Günay A; Goshu GM; Silverman RB; Hande Ozdinler P
    Sci Rep; 2022 Mar; 12(1):5383. PubMed ID: 35354901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential motor neuron involvement in progressive muscular atrophy: a comparative study with amyotrophic lateral sclerosis.
    Riku Y; Atsuta N; Yoshida M; Tatsumi S; Iwasaki Y; Mimuro M; Watanabe H; Ito M; Senda J; Nakamura R; Koike H; Sobue G
    BMJ Open; 2014 May; 4(5):e005213. PubMed ID: 24833696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation.
    Mead RJ; Shan N; Reiser HJ; Marshall F; Shaw PJ
    Nat Rev Drug Discov; 2023 Mar; 22(3):185-212. PubMed ID: 36543887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the upper motor neuron in amyotrophic lateral sclerosis.
    Huynh W; Simon NG; Grosskreutz J; Turner MR; Vucic S; Kiernan MC
    Clin Neurophysiol; 2016 Jul; 127(7):2643-60. PubMed ID: 27291884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edaravone: a new hope for deadly amyotrophic lateral sclerosis.
    Bhandari R; Kuhad A; Kuhad A
    Drugs Today (Barc); 2018 Jun; 54(6):349-360. PubMed ID: 29998226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput drug screens for amyotrophic lateral sclerosis drug discovery.
    McGown A; Stopford MJ
    Expert Opin Drug Discov; 2018 Nov; 13(11):1015-1025. PubMed ID: 30317895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central motor conduction time reveals upper motor neuron involvement masked by lower motor neuron impairment in a significant portion of patients with amyotrophic lateral sclerosis.
    Tokimura R; Murakami T; Ugawa Y
    Clin Neurophysiol; 2020 Aug; 131(8):1896-1901. PubMed ID: 32593964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motor neuron dysfunction in a mouse model of ALS: gender-dependent effect of P2X7 antagonism.
    Cervetto C; Frattaroli D; Maura G; Marcoli M
    Toxicology; 2013 Sep; 311(1-2):69-77. PubMed ID: 23583883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs.
    Jaiswal MK
    Med Res Rev; 2019 Mar; 39(2):733-748. PubMed ID: 30101496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective review of the progress in amyotrophic lateral sclerosis drug discovery over the last decade and a look at the latest strategies.
    DeLoach A; Cozart M; Kiaei A; Kiaei M
    Expert Opin Drug Discov; 2015 Oct; 10(10):1099-118. PubMed ID: 26307158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis.
    Gille B; De Schaepdryver M; Goossens J; Dedeene L; De Vocht J; Oldoni E; Goris A; Van Den Bosch L; Depreitere B; Claeys KG; Tournoy J; Van Damme P; Poesen K
    Neuropathol Appl Neurobiol; 2019 Apr; 45(3):291-304. PubMed ID: 29908069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF cystatin C and diffusion tensor imaging parameters as biomarkers of upper motor neuron degeneration in amyotrophic lateral sclerosis.
    Nakane S; Fujita K; Azuma S; Urushihara R; Kamada M; Harada M; Izumi Y; Kaji R
    Clin Neurol Neurosurg; 2018 Sep; 172():162-168. PubMed ID: 30016754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional spreading pattern is associated with clinical phenotype in amyotrophic lateral sclerosis.
    Maranzano A; Verde F; Colombo E; Poletti B; Doretti A; Bonetti R; Gagliardi D; Meneri M; Maderna L; Messina S; Corti S; Morelli C; Silani V; Ticozzi N
    Brain; 2023 Oct; 146(10):4105-4116. PubMed ID: 37075222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.